Bettina Kulle Andreassen

8PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillanceEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 07, 2026
Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently.

S Hjorth, K F Vandraas, C B Trewin-Nybråten

|Apr 29, 2025
Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancer.

Kaitlyn M Tsuruda, Helga H Hektoen, Christina Aamelfot

|Feb 17, 2025
Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer.

Kaitlyn M Tsuruda, Helga H Hektoen, Denise Reis Costa

|Nov 03, 2024
Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study.

Helga H Hektoen, Kaitlyn M Tsuruda, Lars Fjellbirkeland

|Aug 30, 2023
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.

L Lukas Löfling, Nathalie C Støer, Bettina Kulle Andreassen

|Mar 16, 2023
Identification of Drug-Cancer Associations: A Nationwide Screening Study.

Kasper Bruun Kristensen, Søren Friis, Lars Christian Lund

Pageof 2